{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:06:09Z","timestamp":1760979969345},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,3,1]],"date-time":"1985-03-01T00:00:00Z","timestamp":478483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1985,3]]},"DOI":"10.1007\/bf00428200","type":"journal-article","created":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T23:44:56Z","timestamp":1100130296000},"page":"346-352","source":"Crossref","is-referenced-by-count":131,"title":["Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats"],"prefix":"10.1007","volume":"85","author":[{"given":"J\ufffdrn","family":"Arnt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hyttel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-2999(84)90267-X","volume":"102","author":"J Arnt","year":"1984","unstructured":"Arnt J, Hyttel J (1984) Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur J Pharmacol 102:349?354","journal-title":"Eur J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y-C Cheng","year":"1973","unstructured":"Cheng, Y-C, Prusoff WH (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099?3108","journal-title":"Biochem Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0024-3205(84)90607-6","volume":"34","author":"AV Christensen","year":"1984","unstructured":"Christensen AV, Arnt J, Hyttel J, Larsen J-J Svendsen O (1984) Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529?1540","journal-title":"Life Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(76)90229-6","volume":"35","author":"B Costall","year":"1976","unstructured":"Costall B, Naylor RJ, Pycock C (1976) Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. Eur J Pharmacol 35:275?283","journal-title":"Eur J Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00498827","volume":"323","author":"DM Coward","year":"1983","unstructured":"Coward DM (1983) Apomorphine-induced biphasic circling behaviour in 6-hydroxydopamine-lesioned rats. A pharmacological kindling phenomenon. Naunyn-Schmiedeberg's Arch Pharmacol 323:49?53","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.2042-7158.1983.tb02957.x","volume":"35","author":"S Fleminger","year":"1983","unstructured":"Fleminger S, Van de Waterbeemd H, Rupniak NMJ, Reavill C, Testa B, Jenner P, Marsden CD (1983) Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat. J Pharm Pharmacol 35:363?368","journal-title":"J Pharm Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00004714-198212000-00002","volume":"2","author":"RW Fuller","year":"1982","unstructured":"Fuller RW, Clemens JA, Hynes III MD (1982) Degree of selectivity of pergolide as an agonist at presynaptic versus or treatment of tardive dyskinesia. J Clin Psychopharmacol 2:371?375","journal-title":"J Clin Psychopharmacol"},{"key":"CR8","first-page":"354","volume":"227","author":"RW Fuller","year":"1983","unstructured":"Fuller RW, Hemrick-Luecke SK, Wong DT, Pearson D, Threlkeld PG, Hynes III MD (1983) Altered behavioral response to a D2 agonist, LY 141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats. J Pharmacol Exp Ther 227:354?359","journal-title":"J Pharmacol Exp Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.33.11.1489","volume":"33","author":"O Gershanik","year":"1983","unstructured":"Gershanik O, Heikkila RE, Duvoisin RC (1983) Behavioral correlations of dopamine receptor activation. Neurology 33:1489?1492","journal-title":"Neurology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1073\/pnas.77.6.3725","volume":"77","author":"M Goldstein","year":"1980","unstructured":"Goldstein M, Lieberman A, Lew JY, Asano K, Rosenfeld MR, Makman MH (1980) Interaction of pergolide with central dopaminergic receptors. Proc natl Acad Sci USA 77:3725?3728","journal-title":"Proc natl Acad Sci USA"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1476-5381.1982.tb09285.x","volume":"77","author":"AJ Gower","year":"1982","unstructured":"Gower AJ, Marriott AS (1982) Pharmacological evidence for the subclassification of central dopamine receptors in the rat. Br J Pharmacol 77:185?194","journal-title":"Br J Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(84)90587-9","volume":"98","author":"M Herrera-Marschitz","year":"1984","unstructured":"Herrera-Marschitz M, Ungerstedt U (1984) Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites. Eur J Pharmacol 98:165?176","journal-title":"Eur J Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0024-3205(78)90033-4","volume":"23","author":"J Hyttel","year":"1978","unstructured":"Hyttel J (1978) Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro. Life Sci 23:551?556","journal-title":"Life Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00427604","volume":"67","author":"J Hyttel","year":"1980","unstructured":"Hyttel J (1980) Further evidence that 3H-cis(Z)-flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum. Psychopharmacology 67:107?109","journal-title":"Psychopharmacology"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0024-3205(81)90150-8","volume":"28","author":"J Hyttel","year":"1981","unstructured":"Hyttel J (1981a) Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro. Life Sci 28:563?569","journal-title":"Life Sci"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00432192","volume":"75","author":"J Hyttel","year":"1981","unstructured":"Hyttel J (1981b) Flupentixol and dopamine receptor selectivity. Psychopharmacology 75:217","journal-title":"Psychopharmacology"},{"key":"CR17","series-title":"Advances in the Biosciences","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/B978-0-08-027391-4.50017-4","volume-title":"Advances in dopamine research","author":"J Hyttel","year":"1982","unstructured":"Hyttel J (1982) Preferential labelling of adenylate cyclase coupled dopamine receptors with thioxanthene neuroleptics. In: Kohsaka M, Shohmori T, Tsukuda Y, Woodruff GN (eds) Advances in dopamine research. Pergamon Press, Oxford, Advances in the Biosciences. pp 147?152"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","volume":"91","author":"J Hyttel","year":"1983","unstructured":"Hyttel J (1983) SCH 23390?the first selective dopamine D-1 antagonist. Eur J Pharmacol 91:153?154","journal-title":"Eur J Pharmacol"},{"key":"CR19","first-page":"462","volume":"226","author":"LC Iorio","year":"1983","unstructured":"Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462?468","journal-title":"J Pharmacol Exp Ther"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93?96","journal-title":"Nature"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0028-3908(80)90079-9","volume":"19","author":"WC Koller","year":"1980","unstructured":"Koller WC, Weiner WJ, Diamon BI, Nausieda PA, Klawans HL (1980) The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent. Neuropharmacology 19:831?837","journal-title":"Neuropharmacology"},{"key":"CR22","volume-title":"The rat brain","author":"JFR K\u00f6nig","year":"1963","unstructured":"K\u00f6nig JFR, Klippel RA (1963) The rat brain. Williams and Wilkins, Baltimore"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/287052a0","volume":"287","author":"MR Kozlowski","year":"1980","unstructured":"Kozlowski MR, Sawyer S, Marshall JF (1980) Behavioural effects and supersensitivity following nigral dopamine receptor stimulation. Nature 287:52?54","journal-title":"Nature"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(83)90387-4","volume":"38","author":"J Lehmann","year":"1983","unstructured":"Lehmann J, Briley M, Langer SZ (1983) Characterization of dopamine autoreceptor and [3H]-spiperone binding sites in vitro with classical and novel receptor agonists. Eur J Pharmacol 38:11?26","journal-title":"Eur J Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(80)90486-0","volume":"62","author":"C Oberlander","year":"1980","unstructured":"Oberlander C, Dumont C, Boissier JR (1980) Time course of apomorphine-induced circling behaviour after striatal dopamine receptor denervation. Eur J Pharmacol 62:107?110","journal-title":"Eur J Pharmacol"},{"key":"CR26","first-page":"242","volume":"82","author":"KM O'Boyle","year":"1984","unstructured":"O'Boyle KM, Pugh M, Waddington JL (1984) Stereotypy induced by the D2 dopamine agonist RU24213 is blocked by the D2 antagonist RO22-2586 and the D1 antagonist SCH 23390. Br J Pharmacol 82:242","journal-title":"Br J Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-2999(78)90148-6","volume":"50","author":"PE Setler","year":"1978","unstructured":"Setler PE, Sarau HM, Zirkle CL, Saunders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50:419?430","journal-title":"Eur J Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00512467","volume":"323","author":"K Starke","year":"1983","unstructured":"Starke K, Sp\u00e4th L, Lang JD, Adelung C (1983) Further functional in vitro comparison of pre-and postsynaptic dopamine receptors in the rabbit caudate nucleus. Naunyn Schmiedeberg's Arch Pharmacol 323:298?306","journal-title":"Arch Pharmacol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3940(82)90188-4","volume":"34","author":"MS Starr","year":"1982","unstructured":"Starr MS, Summerhayes M (1982) Multifocal brain sites for apomorphine-induced circling and other stereotyped motor behaviour in the 6-hydroxydopamine-lesioned rat. Neurosci Lett 34:277?282","journal-title":"Neurosci Lett"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(82)90420-6","volume":"250","author":"JC Stoof","year":"1982","unstructured":"Stoof JC, Kebabian JW (1982) Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum. Brain Res 250:263?270","journal-title":"Brain Res"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1021\/jm00362a005","volume":"26","author":"RD Titus","year":"1983","unstructured":"Titus RD, Kornfeld EC, Jones ND, Clemens JA, Smalstig EB, Fuller RW, Hahn RA, Hynes III MD, Mason NR, Wong DT, Foreman MM (1983) Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H (or 2H)-pyrazolo[3,4-g]quinoline. J Med Chem 26:1112?1116","journal-title":"J Med Chem"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/292463a0","volume":"292","author":"K Tsuruta","year":"1981","unstructured":"Tsuruta K, Frey EA, Grewe CN, Cote TE, Eskay RL, Kebabian JW (1981) Evidence that LY 141865 specifically stimulates the D-2 dopamine receptor. Nature 292:463?465","journal-title":"Nature"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","volume":"Suppl 367","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69?93","journal-title":"Acta Physiol Scand"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00429198","volume":"73","author":"S Usuda","year":"1981","unstructured":"Usuda S, Nishikori K, Noshiro O, Maeno H (1981) Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity. Psychopharmacology 73:103?109","journal-title":"Psychopharmacology"},{"key":"CR35","first-page":"269","volume":"4","author":"DT Wong","year":"1980","unstructured":"Wong DT, Reid LR (1980) Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide. Commun Psychopharmacol 4:269?275","journal-title":"Commun Psychopharmacol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01249124","volume":"58","author":"DT Wong","year":"1983","unstructured":"Wong DT, Bymaster EP, Reid LR, Fuller RW, Perry KW, Kornfeld EC (1983) Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain. J Neural Transm 58:55?67","journal-title":"J Neural Transm"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00428200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00428200\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00428200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:38:04Z","timestamp":1554835084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00428200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["BF00428200"],"URL":"https:\/\/doi.org\/10.1007\/bf00428200","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}